Fastenal
FAST
$51.02
+1.27%
Fastenal Co. is an industrial distributor that began as a nuts-and-bolts retailer and evolved into a full-line supplier of maintenance, repair, and operations (MRO) products — fasteners, cutting tools, safety equipment, and janitorial supplies — serving manufacturing, construction, and infrastructure customers across North America and beyond. Its competitive identity rests on a dense branch network and, increasingly, an on-site and vending-machine model in which Fastenal embeds its own personnel and inventory-management technology directly inside customer facilities; these on-site locations now outnumber traditional branches and are the firm's primary growth engine, making Fastenal less a catalog distributor and more an outsourced MRO partner with sticky, recurring revenue. The current investor debate centers on whether that on-site/vending flywheel can sustain the double-digit top-line growth the company just delivered — Q2 2026 revenue rose roughly 14.7% year over year — while gross margins drift modestly lower and the stock trades at a premium multiple that leaves little room for execution error. Sentiment is further colored by a cautious sell-side stance (consensus 'hold') and a broader industrial-demand backdrop that investors are watching for signs of a manufacturing recovery.…
FAST
Fastenal
$51.02
Related headlines
Investment Opinion: Should I buy FAST Today?
Rating: Hold. Fastenal is a high-quality compounder — 14.74% revenue growth, a 21.02% operating margin and 31.91% ROE — but at $51.02 the stock trades above the 13-analyst average target of $50.68 and carries a 'hold' consensus (mean rating 2.72), so the risk/reward is balanced rather than attractive. The core thesis is that the on-site/vending flywheel is real and durable, but the current multiple already pays for it.
The supporting evidence is mixed but tilts toward quality over value. Revenue grew 14.74% YoY to $2.387B in Q2 2026 with clean sequential EPS progression ($0.26 → $0.30 → $0.33), operating margin held at 21.02% versus 20.96% a year earlier, and the balance sheet carries only 0.112 debt-to-equity with a 4.85 current ratio. However, the 36.48x trailing PE, 25.11x EV/EBITDA and 3.65 PEG sit in the upper third of the stock's 23x–42x historical band, TTM FCF yield is just ~2.24%, and the implied upside to the average target is -0.7% — the analyst dispersion ($39.90 low to $60.00 high) signals genuine disagreement about the deserved multiple.
The biggest risks that could invalidate the thesis are a deceleration in on-site signings, continued gross-margin erosion below 44%, and further working-capital-driven FCF weakness. This Hold would upgrade to Buy if the stock consolidated toward the $45–$46 area (roughly 31x forward earnings) while revenue growth held above 12%, or if estimates rose enough to lift the average target meaningfully above $55; it would downgrade to Sell if revenue growth fell below 10% or gross margin broke below 43.5%. Verdict: fairly valued to modestly overvalued relative to its own history and the distribution sector — a great business at a full price.
Sign up to view all
FAST 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Fastenal's 12-month outlook, with a consensus price target around $51.07 and implied upside of +0.1% versus the current price.
Average Target
$51.07
0 analysts
Implied Upside
+0.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$40 - $60
Analyst target range
Coverage is moderate, with 13 analysts and a consensus recommendation of 'hold' (mean rating 2.72 on a scale where 1 is strong buy and 5 is strong sell), reflecting a sell-side community that respects the franchise but views the valuation as full. The average target price of $50.68 sits slightly below the current $51.02, implying roughly -0.7% downside to consensus — a neutral-to-cautious signal that stands in contrast to the stock's strong price momentum and suggests analysts see the recent rally as having run ahead of their fundamental models. Consensus forward EPS of $1.80 (range $1.68–$1.85) and revenue of $12.70 billion (range $12.05–$12.95 billion) imply the Street expects continued high-teens growth, so the muted target is a valuation call rather than a growth-skepticism call. The target range is wide — $39.90 low to $60.00 high, a spread of about 50% around the average — which signals genuine disagreement about the multiple the business deserves. The $60 high target (roughly +17.6% from current) would require multiple expansion toward 33x forward earnings on the high end of EPS estimates, effectively assuming the market re-rates Fastenal as a secular compounder immune to industrial cyclicality. The $39.90 low target (about -21.8%) implies compression toward the low-20s earnings multiple, consistent with a manufacturing slowdown or margin erosion from on-site mix. Institutional ratings show a stable, unenthusiastic pattern: Barclays, Morgan Stanley, and DA Davidson have all reiterated Equal Weight/Neutral through 2026 with no upgrades, while Baird has maintained Outperform — a split that mirrors the hold consensus and suggests limited near-term catalyst for rating changes. The combination of a hold consensus, an average target at or below the current price, and a wide dispersion argues for patience: the stock's technical strength is real, but the analyst community is not yet validating further upside, and the risk/reward at 96% of the 52-week range is asymmetric to the downside until either estimates rise or the price consolidates.
Bulls vs Bears: FAST Investment Factors
The bull case rests on genuinely high-quality fundamentals: 14.74% revenue growth, a 21.02% operating margin, 31.91% ROE and a near-debt-free balance sheet, all confirmed by market leadership (+9.47 points of 3-month relative strength). The bear case is almost entirely about price: 36.5x earnings, a 3.65 PEG, a 'hold' consensus and an average target of $50.68 that sits below the current $51.02. On balance the evidence favors the bear side for forward returns at today's price — not because the business is deteriorating, but because the multiple already discounts flawless execution, and the analyst community is not validating further upside. The single most important tension is whether the on-site/vending flywheel can keep revenue growing at high-teens rates while gross margin drifts lower; if growth holds and margins stabilize, the premium is defensible, but any deceleration would likely compress the PE toward its 30x midpoint.
Bullish
- Double-digit revenue growth accelerating: Q2 2026 revenue of $2.387B rose 14.74% YoY versus $2.080B, and the sequential path ($2.027B Q4 2025 → $2.202B Q1 2026 → $2.387B Q2 2026) shows compounding momentum rather than a one-quarter spike. Consensus forward revenue of $12.70B implies the on-site/vending flywheel keeps delivering high-teens expansion.
- Fortress balance sheet, elite returns: Debt-to-equity of just 0.112, a current ratio of 4.85, ROE of 31.91% and ROA of 21.97% are exceptional for a distributor and reflect high asset turnover with almost no leverage. This gives Fastenal the capacity to fund on-site capex and a 79.8% payout dividend without balance-sheet stress.
- Operating leverage holding margins flat: Q2 2026 operating income of $501.8M (21.02% margin) grew 15.0% YoY from $436.1M (20.96%), so dollar profits grew faster than the 14.74% top line while gross margin slipped only from 45.32% to 44.56%. The 20.19% operating margin is well above the ~10–15% typical of broad-line distributors.
- Persistent market leadership: Relative strength versus SPY is positive on every horizon: +9.47 points over 3 months (SPY +2.69% vs FAST +12.16%), +6.06 points over 1 year (FAST +21.59% vs SPY +15.53%), and +14.23 points YTD. The stock is up 26.16% YTD and sits at ~96.4% of its 52-week range, confirming it is a leader rather than a beta beneficiary.
Bearish
- Premium multiple leaves no margin of safety: At 36.48x trailing and 36.19x forward PE, 25.11x EV/EBITDA, 11.68x book and a 3.65 PEG, Fastenal trades in the upper third of its own 23x–42x historical PE band. A re-rating to the ~30x midpoint alone implies roughly 15–18% downside on multiple compression.
- Analyst consensus offers no upside: The 13-analyst consensus is 'hold' (mean 2.72) with an average target of $50.68 — about -0.7% versus the $51.02 price. Barclays, Morgan Stanley and DA Davidson have reiterated Equal Weight/Neutral through 2026 with no upgrades, so the sell-side is making a valuation call, not a growth call.
- Free cash flow conversion deteriorating: TTM FCF of $1.032B on a $46.05B market cap is only a ~2.24% FCF yield, and Q2 2026 FCF collapsed to $78.2M from $319.5M in Q1 as working capital absorbed $166.4M (receivables +$116M, inventory +$44.8M). The dividend-plus-capex coverage ratio of 0.42 means growth investment and the dividend together exceed quarterly FCF.
- Structural gross-margin drift: Gross margin has slid from 45.27% in Q3 2025 to 44.56% in Q2 2026 as mix shifts toward larger, lower-margin on-site contracts. This looks structural rather than temporary, and with a 79.8% payout ratio there is limited cushion if margin pressure intensifies.
FAST Technical Analysis
Fastenal is in a sustained uptrend: the stock is up 21.59% over the past year and 26.16% year to date, and at $51.02 it sits at roughly 96.4% of its 52-week range (low $38.97, high $52.92) — a positioning that signals strong momentum but also meaningful proximity to overextension, with only about $1.90 of headroom to the prior high. The recovery has been orderly rather than parabolic, with a max drawdown of -20.17% over the period indicating the trend absorbed a meaningful correction before resuming higher. Short-term momentum is positive but decelerating relative to the intermediate trend: the stock is up 4.06% over the past month and 12.16% over three months, meaning the 3-month gain is roughly triple the 1-month gain, a classic signature of a maturing leg rather than an accelerating one. Importantly, the 1-month move outpaces the S&P 500's 1.22% by a relative-strength spread of 2.84 points, and the 3-month relative strength of +9.47 points is the strongest reading across all horizons — confirming Fastenal is a market leader, not merely a beta beneficiary. The 1-year relative strength of +6.06 points versus SPY's 15.53% gain reinforces persistent outperformance. Key levels are well defined: support clusters near the $49.00–$49.50 shelf that held repeatedly through September, with the 52-week low at $38.97 as the deeper structural floor, while resistance sits at the $52.92 high and the psychological $52–$53 zone. A breakout above $52.92 on volume would confirm trend continuation and likely trigger momentum-chasing flows, whereas a breakdown below $49 would signal a failed breakout and open a path toward the $45–$46 congestion area from July. Volatility is a critical consideration: beta of 0.69 means Fastenal is roughly 31% less volatile than the market, which supports larger position sizing for risk-parity allocators but also implies the stock will lag in a sharp broad-market rally — a defensive profile consistent with its industrial-staples cash flows. Average volume of roughly 10.5 million shares provides ample liquidity, and a short ratio of 4.95 days indicates no meaningful bearish crowding.
Beta
0.69
0.69x market volatility
Max Drawdown
-20.2%
Largest decline past year
52-Week Range
$39-$53
Price range past year
Annual Return
+21.6%
Cumulative gain past year
| Period | FAST Return | S&P 500 |
|---|---|---|
| 1m | +4.1% | +0.2% |
| 3m | +12.2% | +2.9% |
| 6m | +11.4% | +8.4% |
| 1y | +21.6% | +14.9% |
| ytd | +26.2% | +11.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
FAST Fundamental Analysis
Revenue is growing at a healthy and stable clip: Q2 2026 revenue of $2.387 billion rose 14.74% year over year versus $2.080 billion in Q2 2025, and the sequential progression from $2.202 billion in Q1 2026 and $2.027 billion in Q4 2025 shows consistent upward momentum rather than a one-quarter spike. Trailing four-quarter revenue of roughly $8.74 billion (Q3 2025 through Q2 2026) compares favorably to the prior-year period, and consensus estimates revenue of $12.70 billion for the forward year — implying continued double-digit expansion that would require the on-site and vending rollout to keep compounding. The growth is volume-and-signings driven rather than price-led, which is the higher-quality variety, though the modest sequential gross-margin drift (45.27% in Q3 2025 to 44.56% in Q2 2026) suggests mix shift toward larger, lower-margin on-site contracts is a structural, not temporary, feature of the model. Profitability is robust and improving on the operating line: Q2 2026 net income of $382.8 million on a 16.04% net margin and 44.56% gross margin, with operating income of $501.8 million (21.02% operating margin) versus $436.1 million (20.96%) a year earlier — dollar profits grew 15.0% while margins held essentially flat, a solid outcome given the gross-margin headwind. The quarterly EPS progression from $0.26 (Q4 2025) to $0.30 (Q1 2026) to $0.33 (Q2 2026) demonstrates clean sequential earnings acceleration, and the 20.19% operating margin sits comfortably above the ~10–15% typical of broad-line distributors, reflecting Fastenal's value-added service model. Note the reported key-metric EPS of $0.027 appears to be a data artifact inconsistent with the $0.33 quarterly diluted EPS in the filings; the quarterly figures should be treated as authoritative. The balance sheet is fortress-like: debt-to-equity of just 0.112, a current ratio of 4.85, and ROE of 31.91% with ROA of 21.97% — returns that are exceptional for a distribution business and reflect high asset turnover plus minimal leverage. Free cash flow is the one area warranting scrutiny: TTM FCF of $1.032 billion against a $46.05 billion market cap implies an FCF yield of only ~2.24%, and Q2 2026 FCF collapsed to $78.2 million from $319.5 million in Q1 as working capital absorbed $166.4 million (receivables up $116 million, inventory up $44.8 million) — a classic growth-working-capital drag rather than a profitability problem. Capital returns remain generous, with $275.4 million of dividends paid in Q2 alone against a payout ratio of 79.8%, though the dividend-plus-capex coverage ratio of 0.42 in the latest historical-ratio snapshot highlights that growth capex and the dividend together exceed quarterly free cash flow, meaning the company periodically leans on its cash balance ($54.1 million at quarter-end, down from $308.6 million) rather than debt.
Quarterly Revenue
$2.4B
2026-06
Revenue YoY Growth
+14.7%
YoY Comparison
Gross Margin
44.6%
Latest Quarter
Free Cash Flow
$1.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is FAST Overvalued?
Because Fastenal is solidly profitable (Q2 2026 net income of $382.8 million), the PE ratio is the appropriate primary metric, and it currently stands at 36.48x trailing and 36.19x forward — an unusually narrow gap that implies the market expects essentially no earnings acceleration over the next twelve months, with forward EPS of roughly $1.41 implied by the multiple versus consensus estimates of $1.80 (a discrepancy suggesting the forward PE may be computed on a different fiscal-year basis). The PEG ratio of 3.65 is the more telling figure: at 36x earnings against high-teens growth, investors are paying roughly 3.6x growth, a rich price that demands sustained double-digit expansion. On the secondary metrics, the picture is even fuller: PS of 5.62x, EV/Sales of 6.39x, EV/EBITDA of 25.11x, and a price-to-book of 11.68x — all consistent with a premium-quality compounder rather than a value distributor. Peer comparison is constrained by the absence of a supplied industry-average multiple set, but the internal evidence is instructive: Fastenal's 20.19% operating margin and 31.91% ROE are well above what typical industrial distributors earn, which justifies a premium — yet a 25.1x EV/EBITDA and 36.5x PE leave the stock priced for perfection relative to the distribution sector's historical mid-teens to low-20s earnings multiples. The 2.18% dividend yield and 79.8% payout ratio offer modest income support but little valuation cushion. Historically, Fastenal's own PE band has ranged from roughly 23x (Q3 2022) to 42x (Q3 2025), and the current 36.5x sits in the upper third of that range — below the 2025 peak but well above the 2022–2023 trough. Its PS ratio of 5.62x compares to a historical range of roughly 14.6x to 26.4x on the quarterly ratio series, though those figures appear computed on a different share-count basis and should be read directionally rather than absolutely; the more reliable signal is the PE, which shows the market pricing in optimistic but not euphoric expectations. The takeaway is that valuation offers limited margin of safety: at 36x earnings with a 3.65 PEG, the stock needs continued high-teens revenue growth and stable margins to justify its multiple, and any deceleration would likely compress the PE toward its 30x historical midpoint — implying roughly 15–18% downside on multiple alone.
PE
36.5x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 23x~42x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
25.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on cash conversion and margin mix rather than solvency. TTM free cash flow of $1.032B against a $46.05B market cap is a thin ~2.24% FCF yield, and Q2 2026 FCF fell to $78.2M from $319.5M in Q1 as working capital absorbed $166.4M (receivables up $116M, inventory up $44.8M) — a growth drag that will persist as long as on-site signings accelerate. Gross margin has drifted from 45.27% (Q3 2025) to 44.56% (Q2 2026) as larger on-site contracts carry lower margins, and with a 79.8% payout ratio and a dividend-plus-capex coverage ratio of 0.42, the company is drawing on its cash balance ($54.1M, down from $308.6M) rather than debt. The offsetting strength is a 0.112 debt-to-equity ratio and 4.85 current ratio, which mean these are efficiency risks, not survival risks.
Market and competitive risks are dominated by valuation compression. At 36.48x trailing PE, 25.11x EV/EBITDA and 11.68x price-to-book, Fastenal trades at a premium to the distribution sector's historical mid-teens to low-20s earnings multiples, and a PEG of 3.65 means investors are paying ~3.6x growth. Beta of 0.69 cushions broad-market selloffs but also means the stock will lag a sharp rally, and the 3-month relative-strength spread of +9.47 points is the kind of leadership that tends to mean-revert. Competitive pressure comes from larger distributors and digital procurement platforms encroaching on MRO wallets, while the manufacturing-demand backdrop remains the key swing factor for on-site signings; the muted sell-side stance (hold consensus, $50.68 average target) suggests analysts see the recent rally as having outrun their models.
In a worst-case scenario, a manufacturing slowdown stalls on-site signings, revenue growth decelerates from 14.74% toward high single digits, and gross margin continues its slide below 44%, forcing the market to re-rate the stock from 36.5x toward the low-20s multiple implied by the $39.90 analyst low target. That path would take the shares to roughly $39.90–$40, about -22% from $51.02, and a deeper de-rating toward the $38.97 52-week low would imply roughly -24%. The stock has already demonstrated a -20.17% max drawdown over the past year, so a drawdown of this magnitude is historically plausible rather than theoretical; the realistic downside from current levels is therefore in the -20% to -24% range, with the $49.00–$49.50 support shelf as the first warning level and $45–$46 as the next stop.
FAQ
The most severe risk is valuation compression: at 36.48x earnings with a 3.65 PEG, a move toward the low-20s multiple implied by the $39.90 analyst low target would cost roughly 22%. Second is growth deceleration — the 14.74% Q2 2026 revenue growth depends on continued on-site signings, and a manufacturing slowdown could stall the flywheel. Third is margin erosion, with gross margin already down from 45.27% in Q3 2025 to 44.56% in Q2 2026 as larger on-site contracts carry lower margins. Fourth is cash conversion, where Q2 2026 FCF fell to $78.2M from $319.5M in Q1 as working capital absorbed $166.4M, leaving a TTM FCF yield of only ~2.24%.
The 12-month outlook is split into three scenarios: a 55% base case of $49–$53, anchored by the $50.68 average analyst target and consensus EPS of $1.80; a 25% bear case of $39.90–$45, aligned with the analyst low target and a de-rating toward low-20s multiples; and a 20% bull case of $58–$60, aligned with the $60 high target and a re-rating toward 32–33x forward earnings. The base case is most likely because revenue growth near 14–15% and stable margins would let earnings catch up to the multiple without requiring either a re-rating or a de-rating. The key assumption is that on-site signings keep compounding and gross margin holds above 44%.
Fastenal screens as fairly valued to modestly overvalued. The 36.48x trailing and 36.19x forward PE sit in the upper third of the stock's own 23x–42x historical band, and the 25.11x EV/EBITDA, 11.68x price-to-book and 3.65 PEG are all consistent with a premium-quality compounder rather than a value distributor. The premium is partly earned — a 20.19% operating margin and 31.91% ROE are well above the ~10–15% margins typical of broad-line distributors — but the market is paying ~3.6x growth, which assumes high-teens revenue expansion continues. A re-rating to the ~30x historical midpoint would imply roughly 15–18% downside on multiple alone, so the valuation embeds optimistic but not euphoric expectations.
From a risk/reward perspective the setup is balanced rather than compelling. The 13-analyst average target of $50.68 sits about 0.7% below the $51.02 price, and the consensus rating is 'hold' at 2.72, so the sell-side sees little upside from here. The business quality is high — 14.74% revenue growth, a 21.02% operating margin and 31.91% ROE — but the 36.48x trailing PE and 3.65 PEG leave little room for error, and the biggest downside risk is a de-rating toward the $39.90 analyst low target, roughly -22%. It is a reasonable buy for long-term investors adding on pullbacks toward the $45–$46 area, but at 96.4% of the 52-week range the current entry offers an asymmetric risk profile.
Fastenal is better suited to long-term holding than short-term trading. Beta of 0.69 makes it roughly 31% less volatile than the market, which limits the payoff from tactical trading, while the 2.18% dividend yield and 79.8% payout ratio reward patient ownership. The stock is in a maturing uptrend — up 12.16% over three months versus 4.06% over one month — and sits only ~$1.90 below its $52.92 high, so near-term upside is limited. A minimum holding period of 2–3 years is appropriate to let the on-site/vending flywheel compound earnings and to ride out the -20.17% drawdowns the stock has historically experienced.